Renflexis 100 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FM57Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,159
Award facts
- Contract value 100% obligated
- $11,158.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 17, 2026, for Renflexis 100 mg vials with a ceiling value of $11,158.78.
Place of performance is Conshohocken, PA. The ultimate completion date is February 18, 2026. This is a firm fixed-price order issued under no set-aside.
Quick answers
Who was awarded contract SPE2DR26FM57Q?
SPE2DR26FM57Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 17, 2026.
How much is contract SPE2DR26FM57Q worth?
The government has obligated $11,159 on SPE2DR26FM57Q.
Is contract SPE2DR26FM57Q an order under another contract?
Yes. SPE2DR26FM57Q is a delivery order under SPE2DR25D2007, an indefinite delivery contract.
Was contract SPE2DR26FM57Q competed?
The extent of competition for SPE2DR26FM57Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award